D.E. Shaw & Co’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-25,584
Closed -$23.2K 3217
2024
Q3
$23.2K Sell
25,584
-120,607
-82% -$109K ﹤0.01% 2967
2024
Q2
$146K Sell
146,191
-40,436
-22% -$40.3K ﹤0.01% 2866
2024
Q1
$276K Buy
+186,627
New +$276K ﹤0.01% 2640
2023
Q4
Sell
-51,220
Closed -$60.4K 3230
2023
Q3
$60.4K Sell
51,220
-71,461
-58% -$84.3K ﹤0.01% 2717
2023
Q2
$173K Buy
+122,681
New +$173K ﹤0.01% 2635
2022
Q3
Sell
-10,886
Closed -$17K 4042
2022
Q2
$17K Sell
10,886
-44,585
-80% -$69.6K ﹤0.01% 3864
2022
Q1
$85K Sell
55,471
-199,346
-78% -$305K ﹤0.01% 3779
2021
Q4
$624K Buy
254,817
+67,331
+36% +$165K ﹤0.01% 2990
2021
Q3
$472K Buy
187,486
+162,267
+643% +$409K ﹤0.01% 2868
2021
Q2
$72K Buy
+25,219
New +$72K ﹤0.01% 3384
2019
Q4
Sell
-10,354
Closed -$10K 2737
2019
Q3
$10K Buy
+10,354
New +$10K ﹤0.01% 2519
2018
Q2
Sell
-15,386
Closed -$36K 2650
2018
Q1
$36K Sell
15,386
-114,543
-88% -$268K ﹤0.01% 2466
2017
Q4
$244K Sell
129,929
-427
-0.3% -$802 ﹤0.01% 2337
2017
Q3
$324K Buy
130,356
+47,513
+57% +$118K ﹤0.01% 2207
2017
Q2
$228K Sell
82,843
-54,643
-40% -$150K ﹤0.01% 2228
2017
Q1
$415K Buy
137,486
+10,301
+8% +$31.1K ﹤0.01% 2048
2016
Q4
$402K Buy
127,185
+33,790
+36% +$107K ﹤0.01% 2119
2016
Q3
$319K Buy
93,395
+74,404
+392% +$254K ﹤0.01% 2178
2016
Q2
$43K Sell
18,991
-42,394
-69% -$96K ﹤0.01% 2482
2016
Q1
$154K Buy
61,385
+9,444
+18% +$23.7K ﹤0.01% 2431
2015
Q4
$172K Buy
51,941
+23,710
+84% +$78.5K ﹤0.01% 2463
2015
Q3
$68K Sell
28,231
-20,033
-42% -$48.3K ﹤0.01% 2480
2015
Q2
$141K Buy
48,264
+1,528
+3% +$4.46K ﹤0.01% 2513
2015
Q1
$187K Buy
46,736
+7,219
+18% +$28.9K ﹤0.01% 2383
2014
Q4
$119K Buy
39,517
+3,064
+8% +$9.23K ﹤0.01% 2389
2014
Q3
$92K Sell
36,453
-26,050
-42% -$65.7K ﹤0.01% 2282
2014
Q2
$154K Buy
62,503
+1,379
+2% +$3.4K ﹤0.01% 2229
2014
Q1
$162K Sell
61,124
-35,384
-37% -$93.8K ﹤0.01% 2199
2013
Q4
$280K Buy
+96,508
New +$280K ﹤0.01% 2189